News
-
Whistleblower Protection Program
-
The future of high-speed rail in the U.S. and beyond: Wayne State receives grant to examine development of high-speed rail in the U.S.
-
Wayne State University receives $1.7 million NIH research award to discover novel treatments for methamphetamine-abuse associated neurotoxicity
-
Wayne State Receives $1.7 Million NIH Grant to Discover Novel Treatments for Methamphetamine-Abuse
-
$1.7 million NIH grant to Wayne State to discover treatments for methamphetamine-abuse
-
Algae could provide weapon against invader mussels
-
Algae could provide weapon against invader mussels
-
Wayne State Gets $325K Grant To Battle Invasive Species In Great Lakes
-
Wayne State University receives grant from USGS to advance ecological restoration efforts in the Great Lakes
-
Wayne State professor receives prestigious NSF Early Career award; research to impact metro Detroit schools' astronomy programs
-
Wayne State professor receives NSF CAREER award; research to impact Detroit-area schools
-
Wayne State Professor Receives Prestigious NSF Early Career Award; Research to Impact Metro Detroit Schools' Astronomy Programs
-
'Super circles' to lessen rush-hour headaches
-
'Super circles' to lessen rush-hour traffic congestion
-
'Super circles' to lessen rush-hour headaches
-
Light a fire in your relationship: Wayne State University research says double dating may be the answer to a perfect Valentine's Day
-
Double date, not candle-lit dinner, can reignite passion
-
Valentine's Day Idea: Try A Double Date To Reignite Relationship Flames
-
Single gene that separates queen bee from workers discovered
-
Research led by Wayne State discovers single gene in bees separating queens from workers
-
FDA approves new MS treatment regimen developed at Wayne State University; Higher dose, fewer injections for patients around the world
-
Research team led by Wayne State discovers single gene in bees separating queens from workers
-
FDA Approves New MS Treatment Regimen Developed at Wayne State University
-
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mL
-
Potential treatment to improve heart health in hemodialysis patients